GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Cardinal Health Inc (NYSE:CAH) » Definitions » EBITDA per Share

CAH (Cardinal Health) EBITDA per Share : $12.42 (TTM As of Mar. 2025)


View and export this data going back to 1983. Start your Free Trial

What is Cardinal Health EBITDA per Share?

Cardinal Health's EBITDA per Share for the three months ended in Mar. 2025 was $3.93. Its EBITDA per Share for the trailing twelve months (TTM) ended in Mar. 2025 was $12.42.

During the past 12 months, the average EBITDA per Share Growth Rate of Cardinal Health was 80.50% per year. During the past 3 years, the average EBITDA per Share Growth Rate was 22.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBITDA per Share growth rate using EBITDA per Share data.

The historical rank and industry rank for Cardinal Health's EBITDA per Share or its related term are showing as below:

CAH' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: -73.1   Med: 8.6   Max: 84.5
Current: 22

During the past 13 years, the highest 3-Year average EBITDA per Share Growth Rate of Cardinal Health was 84.50% per year. The lowest was -73.10% per year. And the median was 8.60% per year.

CAH's 3-Year EBITDA Growth Rate is ranked better than
81.63% of 98 companies
in the Medical Distribution industry
Industry Median: 5.3 vs CAH: 22.00

Cardinal Health's EBITDA for the three months ended in Mar. 2025 was $946 Mil.

During the past 12 months, the average EBITDA Growth Rate of Cardinal Health was 77.50% per year. During the past 3 years, the average EBITDA Growth Rate was 15.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBITDA Growth Rate using EBITDA data.

During the past 13 years, the highest 3-Year average EBITDA Growth Rate of Cardinal Health was 107.80% per year. The lowest was -73.80% per year. And the median was 16.60% per year.


Cardinal Health EBITDA per Share Historical Data

The historical data trend for Cardinal Health's EBITDA per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cardinal Health EBITDA per Share Chart

Cardinal Health Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
EBITDA per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -8.95 4.37 0.20 5.49 7.94

Cardinal Health Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
EBITDA per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.23 2.37 3.08 3.04 3.93

Cardinal Health EBITDA per Share Calculation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Cardinal Health's EBITDA per Share for the fiscal year that ended in Jun. 2024 is calculated as

EBITDA per Share(A: Jun. 2024 )
=EBITDA/Shares Outstanding (Diluted Average)
=1962/247.000
=7.94

Cardinal Health's EBITDA per Share for the quarter that ended in Mar. 2025 is calculated as

EBITDA per Share(Q: Mar. 2025 )
=EBITDA/Shares Outstanding (Diluted Average)
=946/241.000
=3.93

EBITDA per Share for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $12.42

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cardinal Health  (NYSE:CAH) EBITDA per Share Explanation

EBITDA is a cash flow measure that ignores changes in working capital. EBITDA minus Depreciation, and Amortization (DA) equals EBIT. EBIT is profit before interest and taxes. Of course, Interest and taxes need to be paid.

While depreciation and amortization expenses do not need to be paid in cash, assets - especially tangible assets - do need to be replaced over time. EBITDA is not a measure of profit in any sense. EBITDA is a measure of cash generation by a business where the uses of that cash may be more or less discretionary depending on the nature of the business.

The EBITDA of a TV station is largely discretionary. Owners may use much of the EBITDA generated by a TV station as they see fit. The EBITDA of a railroad is largely non-discretionary. Owners must use much of the EBITDA generated by a railroad to replace the physical assets of the railroad or the business will literally fall apart over time.

EBITDA can be thought of as the cash a business generates that is available to:

Add more inventory
Add more receivables
Replace property, plant, and equipment
Add more property, plant, and equipment
Pay interest
Pay taxes
And finally: pay owners

EBITDA is widely used in financial analysis because Depreciation and Amortization are not present day cash expenses. Depreciation and amortization are the spreading out of the costs of assets over the time in which those assets provide benefits. Today's depreciation and amortization expenses relate to assets bought in the past. The assets being expensed may or may not need to be replaced in the future. And the cost to replace the assets may be more or less than it was in the past. For this reason, the depreciation and amortization expenses a company records in the present year may have no relationship to the actual cash costs needed to maintain its assets in future years.

A company's depreciation expense depends on both its expectations about the assets it owns and its choice of accounting methods. Two companies owning identical assets may have different depreciation expenses because they have different expectations about the useful lives of those assets and because they make different accounting choices.

Analysts use EBITDA to remove this element of personal choice from a company's accounting statements. The use of EBITDA is an attempt to make the results of different companies more comparable and uniform.


Be Aware

Although depreciation is not a cash cost, it is a real business cost because the company has to pay for the fixed assets when they purchase them. Both Warren Buffett and Charlie Munger hate the idea of EBITDA because in this calculation, depreciation is not counted as an expense.

EBITDA over Revenue is a good metric for comparing the operating efficiencies between companies because EBITDA is less vulnerable to companies' accounting choices. For this reason, EBITDA is used in ranking the Predictability of Companies.


Cardinal Health EBITDA per Share Related Terms

Thank you for viewing the detailed overview of Cardinal Health's EBITDA per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Cardinal Health Business Description

Address
7000 Cardinal Place, Dublin, OH, USA, 43017
Cardinal Health is one of three leading pharmaceutical wholesalers in the US, engaged in sourcing and distributing of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. Cardinal, Cencora, and McKesson hold well over 90% of the US pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.
Executives
Mary C. Scherer officer: Chief Accounting Officer 6026 LUDWIG STREET, POWELL OH 43065
Jessica L Mayer officer: Chief Legal/Compliance Officer 7000 CARDINAL PLACE, DUBLIN OH 43017
Ola M Snow officer: Chief Human Resources Officer 7000 CARDINAL PLACE, DUBLIN OH 43017
Stephen M Mason officer: CEO, Medical Segment 7000 CARDINAL PLACE, DUBLIN OH 43017
Jason M. Hollar officer: Chief Financial Officer 3333 BEVERLY ROAD, HOFFMAN ESTATES IL 60179
Aaron E Alt officer: Chief Financial Officer 3001 COLORADO BLVD., DENTON TX 76210
Michelle D. Greene officer: Chief Information Officer 1141 N. OLD WORLD 3RD STREET, UNIT # 2414, MILWAUKEE WI 53203
Deborah Weitzman officer: CEO, Pharmaceutical Segment 600 WEST 22ND STREET, SUITE 300, OAK BROOK IL 60523
Michelle Brennan director 1855 S. GRANT STREET, SAN MATEO CA 94402
Sujatha Chandrasekaran director 77 HOT METAL STREET, PITTSBURGH PA 15203
Christine Mundkur director
Steven Barg director ELLIOTT MANAGEMENT CORPORATION, 40 WEST 57TH STREET, NEW YORK NY 10019
Patricia M English officer: Chief Accounting Officer 7000 CARDINAL PLACE, DUBLIN OH 43017
Sheri H. Edison director 1069 STATE ROUTE 46 EAST, BATESVILLE IN 47006
John H Weiland director C/O C.R BARD INC, 730 CENTRAL AVE, MURRAY HILL NJ 07974